‘Fringe’ treatment for heart disease shows promise, sparks debate

A heart disease treatment that many doctors consider to be fringe medicine unexpectedly showed some promise in a federal study clouded by ethical and scientific controversy, causing debate about the results. The study took 10 years, cost taxpayers $30 million, involved several doctors convicted of felonies and spurred a federal probe into patient safety.

LOS ANGELES — A heart disease treatment that many doctors consider to be fringe medicine unexpectedly showed some promise in a federal study clouded by ethical and scientific controversy, causing debate about the results.

The study took 10 years, cost taxpayers $30 million, involved several doctors convicted of felonies and spurred a federal probe into patient safety.

Even the lead researchers say the treatment cannot be recommended without needing further research.

The study tested chelation (pronounced “kee-LAY’shun”) — periodic intravenous infusions that proponents say may help remove calcium from hardened arteries around the heart.

Chelation has long been used to treat lead poisoning but its safety and value for heart disease are unproven.

The heart disease version involves a different drug that does not have government approval for any use in the United States.

However, alternative medicine practitioners have been ordering it custom-mixed from compounding pharmacies — businesses like the Massachusetts one involved in the current meningitis outbreak — and treating people with it.

More than 100,000 Americans use chelation, often out of distrust of conventional medicine and sometimes in place of established treatments such as cholesterol-lowering medicines and stents to open clogged arteries. Treatments cost $90 to $150 apiece, usually are done weekly for 30 weeks and then less often, and are not covered by insurance.

On Sunday at an American Heart Association conference in Los Angeles, researchers said that a chelation mixture they tested in a study of 1,708 heart attack survivors led to fewer complications — repeat heart attacks, strokes, deaths, hospitalization for chest pain or need for an artery-opening procedure.

Four years after treatment, 26.5 per cent of the chelation group had one of these problems versus 30 per cent of those given dummy infusions.

However, 17 per cent of participants dropped out before the study ended, and only 65 per cent had all 40 infusions they were supposed to get. The missing and incomplete results make it unclear whether the benefit credited to chelation could have occurred by chance alone.

The results have not been published in a medical journal or vetted by independent scientists, another reason doctors are leery.

“The study in my view is inconclusive,” said Dr. Steven Nissen, the Cleveland Clinic’s cardiovascular chief who had no role in the research.

“Chelation has been practiced by physicians on the extreme fringes of medicine” and many involved in this study offer “a variety of other quack therapies,” Nissen said. “I’m really worried about harm coming to the public. Patients should not seek this therapy on the basis of this trial.”

Others including the Heart Association praised the government for doing the study.

“Patients are doing this with or without our permission” so it’s important to test, said Dr. John G. Harold, president-elect of the American College of Cardiology and a doctor at Cedars-Sinai Heart Institute in Los Angeles. He said at least two of his patients had suffered heart failure after getting chelation in Mexico.

Dr. Gary Gibbons, director of the National Heart, Lung and Blood Institute, which funded the study with the National Center for Complementary and Alternative Medicine, called it “a first step” and urged caution about results that suggest “a marginal benefit.”

This chelation seemed safe in this study, where steps were taken to minimize complications and exclude people likely to suffer them, he said. “Further research needs to be done before this can join the mainstream of cardiovascular care.”

Other experts questioned the results, especially because 60 more people in the group getting dummy infusions withdrew from the study than in the group getting chelation. Usually, more people in a treatment group drop out because of side effects, said Dr. Christie Ballantyne, a Baylor College of Medicine heart specialist. To find the opposite is “a red flag” that suggests those who got dummy treatments found that out and decided to drop out.

“There’s something funky going on here,” Ballantyne said. “It raises questions about study conduct,” especially since a difference of one or two people or complications could have nullified the small overall benefit researchers reported.

Dr. Clyde Yancy, a Northwestern University cardiologist and a former Heart Association president, agreed.

“It’s funny business,” he said. “I’ve never seen a study in which one in five people withdrew consent.”

The study’s leader, Dr. Gervasio Lamas of Mount Sinai Medical Center in Miami, said: “The trial needs to be taken for what it is — a step towards future investigation.”

It initially aimed to enrol 2,400 people in the United States and Canada but recruitment lagged and the goal was reset to 1,700.

In 2008, a group of scientists published a long article criticizing the trial, saying participants had not been warned that others had died from chelation. More than half of the doctors running the study make money by selling chelation treatments — a conflict of interest, they complained.

Investigations by the Office for Human Research Protections and the Food and Drug Administration found that several doctors doing the study had been accused of poor practices by state medical boards or involved in insurance fraud, and at least three were convicted felons. That did not prevent them from doing federal research, the government decided, and let the study go on after corrective steps. By that time, 1,500 participants had already been enrolled.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Attendees of the Downtown Red Deer Market, which runs every Wednesday during the summer on Little Gaetz Avenue, have complained about the lack of public washrooms. (Photo contributed by Red Deer Downtown Business Association)
Portable washrooms to be set up in downtown Red Deer this summer

More data is needed before the city invests in a permanent structure

A survey of 3,083 Red Deer residents was done by an online platform on behalf of the City of Red Deer, generating about 11,607 comments.. (File photo)
Red Deerians speak out about COVID-19 concerns in survey

More than 3,000 city residents were surveyed

A Calgary energy company's request for a tax break was turned down by Lacombe County. About $31,000 was owed by a company that went bankrupt and Silverleaf Resources Inc. bought some of their assets.
(Advocate file photo)
Lacombe County turns down oil company’s tax break request

Silverleaf Resources Inc. hoped for break on $31,000 in back taxes

RCMP recovered hundreds of stolen items, including Bibles and historical items stolen from the Bowden Pioneer Museum.
(Photo from RCMP)
Museum artifacts among hundreds of stolen items recovered by RCMP in central Alberta

Second World War and other historical and religious items recovered

Red Deer dogs Bunsen and Beaker helped save a missing pet recently. The two dogs have more than 80,000 followers on Twitter. (Contributed photo)
WATCH: Red Deer science dogs help save lost pet

Red Deer science-communicating dogs Bunsen and Beaker helped rescue a missing pet… Continue reading

Edmonton Oilers' Kailer Yamamoto (56) and Toronto Maple Leafs' Morgan Rielly (44) reach for the rebound from Leafs goalie Michael Hutchinson (30) during second-period NHL action in Edmonton on Monday, March 1, 2021.THE CANADIAN PRESS/Jason Franson
Michael Hutchinson earns 31-save shutout, Maple Leafs blank Oilers 3-0

Michael Hutchinson earns 31-save shutout, Maple Leafs blank Oilers 3-0

Washington Nationals' Ryan Zimmerman watches his solo home run during the third inning of a spring training baseball game against the Houston Astros Monday, March 1, 2021, in West Palm Beach, Fla. (AP Photo/Jeff Roberson)
In-game video returning to baseball for 2021

In-game video returning to baseball for 2021

Winnipeg Jets' Nathan Beaulieu (88) clears the puck in front of goaltender Connor Hellebuyck (37) as Vancouver Canucks' Elias Pettersson (40) looks for the rebound during second-period NHL action in Winnipeg on Monday March 1, 2021. THE CANADIAN PRESS/Fred Greenslade
Three first-period goals pace Vancouver Canucks to 4-0 victory over Winnipeg Jets

Three first-period goals pace Vancouver Canucks to 4-0 victory over Winnipeg Jets

Rugby training gear is shown during a Torotno Wolfpack during a practice at Lamport Stadium in Toronto. Bradford, Featherstone, Leigh, London,  THE CANADIAN PRESS/Neil Davidson
Plans announced to create a grassroots Canadian rugby league co-op

Plans announced to create a grassroots Canadian rugby league co-op

Ottawa Senators left wing Brady Tkachuk (7) and centre Chris Tierney (71) get sandwiched between Flames defencemen Rasmus Andersson (4) and Juuso Valimaki (6) during second-period NHL action in Ottawa on Monday, March 1, 2021. THE CANADIAN PRESS/Sean Kilpatrick
Batherson scores twice for Ottawa Senators in 5-1 win over Calgary Flames

Batherson scores twice for Ottawa Senators in 5-1 win over Calgary Flames

Skiers may be safe from COVID-19, but not those working to keep slopes open: experts

Skiers may be safe from COVID-19, but not those working to keep slopes open: experts

Armas likes what he sees in Toronto FC camp but there are still issues to resolve

Armas likes what he sees in Toronto FC camp but there are still issues to resolve

Team Canada's Jocelyne Larocque celebrates her goal past the U.S.A. with goaltender Embrace Maschmeyer during first period of Women's Rivalry Series hockey action in Vancouver on February 5, 2020. The Canadian women's hockey team opened a camp Monday in Halifax, which is co-hosting the upcoming world championship. Hockey Canada invited 35 players to participate in the seven-day camp closed to the public and media at Scotiabank Centre. The women are training under restrictions because of the COVID-19 pandemic, including a limit of 25 players on the ice at one time. "They will continue to follow strict COVID-19 testing as per team health and safety protocols that have been detailed and approved by Nova Scotia Public Health," Hockey Canada said Monday in a statement. THE CANADIAN PRESS/Jonathan Hayward
Canadian women’s hockey team preparing for possible May world championship

Canadian women’s hockey team preparing for possible May world championship

Most Read